Add to ORKGNaturalistic randomised study controlled against any other treatment to assess the effect of acamprosate in enhancing abstinence on alcoholic patientsEtude pragmatique controlée randomisée de l'efficacité d'acamprosate dans le maintien de l'abstinence du patient alcoolique
Review on literature on the effect of anti-addictive substance in enhancing abstinence of dependent ...
Data on patients' alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were e...
advance access publication 6 June 2005) Abstract — Aims: This review assessed the published data on ...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
ARES is the first naturalistic study to assess the effect of a pharmacological agent in alcoholism: ...
Acamprosate was shown to help to maintain abstinence on alcoholic patients. In this paper, we show t...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
To assess the effectiveness of pharmacotherapy with acamprosate in alcohol-dependent patients treate...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Open label Cohort of Alocholic patients treated with acamprosate, and randomized to nurse accompanie...
An assessment of the efficacy of treatment with acamprosate was, therefore, undertaken using meta-an...
This is the first randomized controlled study that was carried out in naturalistic environment. Resu...
Abstract — Standard treatment for alcohol abuse may include pharmacotherapy to alleviate withdrawal ...
We compared effects of the standard 2 g dose (n=258) and an exploratory 3 g dose of acamprosate (n=8...
Review on literature on the effect of anti-addictive substance in enhancing abstinence of dependent ...
Data on patients' alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were e...
advance access publication 6 June 2005) Abstract — Aims: This review assessed the published data on ...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
ARES is the first naturalistic study to assess the effect of a pharmacological agent in alcoholism: ...
Acamprosate was shown to help to maintain abstinence on alcoholic patients. In this paper, we show t...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
To assess the effectiveness of pharmacotherapy with acamprosate in alcohol-dependent patients treate...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Open label Cohort of Alocholic patients treated with acamprosate, and randomized to nurse accompanie...
An assessment of the efficacy of treatment with acamprosate was, therefore, undertaken using meta-an...
This is the first randomized controlled study that was carried out in naturalistic environment. Resu...
Abstract — Standard treatment for alcohol abuse may include pharmacotherapy to alleviate withdrawal ...
We compared effects of the standard 2 g dose (n=258) and an exploratory 3 g dose of acamprosate (n=8...
Review on literature on the effect of anti-addictive substance in enhancing abstinence of dependent ...
Data on patients' alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were e...
advance access publication 6 June 2005) Abstract — Aims: This review assessed the published data on ...